Authors:
MOFENSON LM
YOGEV R
KORELITZ J
BETHEL J
KRASINSKI K
MOYE J
NUGENT R
RIGAUPEREZ JG
Citation: Lm. Mofenson et al., CHARACTERISTICS OF ACUTE PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND ASSOCIATION WITH LONG-TERM MORTALITY RISK, The Pediatric infectious disease journal, 17(10), 1998, pp. 872-880
Citation: Lm. Mofenson, PERINATAL TRANSMISSION OF HIV IN WOMEN RECEIVING ZIDOVUDINE - ABSTRACT AND COMMENTARY, JAMA, the journal of the American Medical Association, 280(6), 1998, pp. 569-570
Authors:
WILFERT C
BECK DT
FLEISCHMAN AR
MOFENSON LM
PANTELL RH
SCHONBERG SK
SCOTT GB
SKLAIRE MW
WHITLEYWILLIAMS PN
ROGERS MF
Citation: C. Wilfert et al., HUMAN-IMMUNODEFICIENCY-VIRUS ACQUIRED-IMMUNODEFICIENCY-SYNDROME EDUCATION IN SCHOOLS, Pediatrics, 101(5), 1998, pp. 933-935
Authors:
THOMAS DL
VILLANO SA
RIESTER KA
HERSHOW R
MOFENSON LM
LANDESMAN SH
HOLLINGER FB
DAVENNY K
RILEY L
DIAZ C
TANG HB
QUINN TC
Citation: Dl. Thomas et al., PERINATAL TRANSMISSION OF HEPATITIS-C VIRUS FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED MOTHERS, The Journal of infectious diseases, 177(6), 1998, pp. 1480-1488
Citation: Lm. Mofenson, MOTHER-CHILD HIV-2 TRANSMISSION - TIMING AND DETERMINANTS, Obstetrics and gynecology clinics of North America, 24(4), 1997, pp. 759
Citation: Lm. Mofenson, INTERACTION BETWEEN TIMING OF PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE DESIGN OF PREVENTIVE AND THERAPEUTIC INTERVENTIONS, Acta paediatrica, 86, 1997, pp. 1-9
Citation: Lm. Mofenson, REDUCING THE RISK OF PERINATAL HIV-1 TRANSMISSION WITH ZIDOVUDINE - RESULTS AND IMPLICATIONS OF AIDS CLINICAL-TRIALS GROUP PROTOCOL-076, Acta paediatrica, 86, 1997, pp. 89-96
Authors:
HERSHOW RC
RIESTER KA
LEW J
QUINN TC
MOFENSON LM
DAVENNY K
LANDESMAN S
COTTON D
HANSON IC
HILLYER GV
TANG HB
THOMAS DL
Citation: Rc. Hershow et al., INCREASED VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS FROM HEPATITIS-C VIRUS-COINFECTED MOTHERS, The Journal of infectious diseases, 176(2), 1997, pp. 414-420
Authors:
MOFENSON LM
KORELITZ J
MEYER WA
BETHEL J
RICH K
PAHWA S
MOYE J
NUGENT R
READ J
Citation: Lm. Mofenson et al., THE RELATIONSHIP BETWEEN SERUM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVEL, CD4 LYMPHOCYTE PERCENT, AND LONG-TERM MORTALITY RISK IN HIV-1-INFECTED CHILDREN, The Journal of infectious diseases, 175(5), 1997, pp. 1029-1038
Authors:
LAMBERT JS
MOFENSON LM
FLETCHER CV
MOYE J
STIEHM ER
MEYER WA
NEMO GJ
MATHIESON BJ
HIRSCH G
SAPAN CV
CUMMINS LM
JIMENEZ E
ONEILL E
KOVACS A
STEK A
Citation: Js. Lambert et al., SAFETY AND PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IMMUNOGLOBULIN ADMINISTERED TO HIV-INFECTED PREGNANT-WOMEN AND THEIR NEWBORNS, The Journal of infectious diseases, 175(2), 1997, pp. 283-291
Authors:
SCOTT GB
BECK DT
FLEISCHMAN AR
MOFENSON LM
PANTELL RH
SCHONBERG SK
SKLAIRE MW
WHITLEYWILLIAMS PN
WILFERT C
Citation: Gb. Scott et al., MILK, BREAST-FEEDING, AND TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE UNITED-STATES, Pediatric AIDS and HIV infection, 7(1), 1996, pp. 58-60
Authors:
RODRIGUEZ EM
MOFENSON LM
CHANG BH
RICH KC
FOWLER MG
SMERIGLIO V
LANDESMAN S
FOX HE
DIAZ C
GREEN K
HANSON IC
Citation: Em. Rodriguez et al., ASSOCIATION OF MATERNAL DRUG-USE DURING PREGNANCY WITH MATERNAL HIV CULTURE POSITIVITY AND PERINATAL HIV TRANSMISSION, AIDS, 10(3), 1996, pp. 273-282
Citation: Lm. Mofenson, THE ROLE OF ANTIRETROVIRAL THERAPY IN THE MANAGEMENT OF HIV-INFECTIONIN WOMEN, Clinical obstetrics and gynecology, 39(2), 1996, pp. 361-385
Authors:
MOFENSON LM
KORELITZ J
PELTON S
MOYE J
NUGENT R
BETHEL J
Citation: Lm. Mofenson et al., SINUSITIS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CLINICAL CHARACTERISTICS, RISK-FACTORS, AND PROPHYLAXIS, Clinical infectious diseases, 21(5), 1995, pp. 1175-1181
Authors:
SCOTT GB
BECK DT
CONNOR EM
FLEISCHMAN AR
HOPKINS KM
MOFENSON LM
PANTELL RH
SCHONBERG SK
SKLAIRE MW
ROGERS MF
ALLEN JR
Citation: Gb. Scott et al., FROM THE AMERICAN-ACADEMY-OF-PEDIATRICS - REDUCING THE RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ASSOCIATED WITH ILLICIT DRUG-USE, Pediatric AIDS and HIV infection, 6(2), 1995, pp. 111-113
Citation: Em. Connor et Lm. Mofenson, ZIDOVUDINE FOR THE REDUCTION OF PERINATAL HUMAN-IMMUNODEFICIENCY-VIRUS TRANSMISSION - PEDIATRIC AIDS CLINICAL-TRIALS GROUP PROTOCOL-076 - RESULTS AND TREATMENT RECOMMENDATIONS, The Pediatric infectious disease journal, 14(6), 1995, pp. 536-541
Citation: Lm. Mofenson, A CRITICAL-REVIEW OF STUDIES EVALUATING THE RELATIONSHIP OF MODE OF DELIVERY TO PERINATAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS, The Pediatric infectious disease journal, 14(3), 1995, pp. 169-177
Authors:
SCOTT GB
BECK DT
FLEISCHMAN AR
MOFENSON LM
PANTELL RH
SCHOENBERG SK
SKLAIRE MW
WHITLEYWILLIAMS PN
WILFERT C
Citation: Gb. Scott et al., HUMAN-MILK, BREAST-FEEDING, AND TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE UNITED-STATES, Pediatrics, 96(5), 1995, pp. 977-979
Citation: Lm. Mofenson et R. Nugent, PROPHYLACTIC IMMUNE GLOBULIN IN CHILDREN WITH HIV DISEASE, The New England journal of medicine, 332(11), 1995, pp. 750-751
Authors:
MOFENSON LM
RODRIGUEZ EM
HERSHOW R
FOX HE
LANDESMAN S
TUOMALA R
DIAZ C
DANIELS E
BRAMBILLA D
Citation: Lm. Mofenson et al., MYCOBACTERIUM-TUBERCULOSIS INFECTION IN PREGNANT AND NONPREGNANT WOMEN INFECTED WITH HIV IN THE WOMEN AND INFANTS TRANSMISSION STUDY, Archives of internal medicine, 155(10), 1995, pp. 1066-1072